UBS Group AG - MONTEREY BIO ACQUISITION COR ownership

MONTEREY BIO ACQUISITION COR's ticker is and the CUSIP is 61240F207. A total of 10 filers reported holding MONTEREY BIO ACQUISITION COR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MONTEREY BIO ACQUISITION COR
ValueSharesWeighting
Q2 2022$12,0000.0%1,2170.0%0.00%
Q1 2022$12,000
-52.0%
1,217
-50.5%
0.00%
Q4 2021$25,0002,4590.00%
Other shareholders
MONTEREY BIO ACQUISITION COR shareholders Q2 2022
NameSharesValueWeighting ↓
SkyView Investment Advisors, LLC 65,968$666,0000.16%
Spartan Fund Management Inc. 75,000$946,0000.16%
MANGROVE PARTNERS IM, LLC 200,000$2,022,0000.11%
HGC Investment Management Inc. 160,000$1,615,0000.10%
Mint Tower Capital Management B.V. 100,000$1,011,0000.09%
Walleye Capital LLC 14,300$145,0000.00%
CLEAR STREET LLC 2,253$23,0000.00%
Magnetar Financial LLC 15,800$160,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 2,236$22,0000.00%
Tower Research Capital LLC (TRC) 450$5,0000.00%
View complete list of MONTEREY BIO ACQUISITION COR shareholders